Pparg agonistic medicinal compositions
OwnerTadakazu Tamai, Kazuyoshi Yoshikai +1inventors
InventorsTadakazu Tamai, Kazuyoshi Yoshikai, Masazumi Nishikawa
Life of this patent
Estimating the term…
Abstract
The present invention relates to PPARγ-activating pharmaceutical compositions comprising a hydroxylated derivative of a C20-22 polyunsaturated fatty acid or a pharmaceutically acceptable salt thereof, preferably PPARγ-activating pharmaceutical compositions containing a hydroxylated derivative of docosahexaenoic acid (DHA) or a hydroxylated derivative of eicosapentaenoic acid (EPA) or a pharmaceutically acceptable salt thereof, as well as uses of the PPARγ-activating pharmaceutical compositions for treating circulatory diseases, arteriosclerosis, lipid metabolism disorder, diabetes and inflammatory diseases.
Claims8
(not entered)
A PPARγ-activating pharmaceutical composition comprising a hydroxylated derivative of docosahexaenoic acid (DHA) or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.